Personalized Stem Cells, Inc.

Personalized Stem Cells, Inc. operates in the consumer-facing cell therapy services sector, offering autologous stem cell banking. The company's core process involves extracting a patient's adipose-derived stem cells, expanding them to tens of millions in culture, and cryogenically storing them for future physician-directed treatments, aiming to provide a non-surgical option for conditions like osteoarthritis. Led by a team with deep experience in regenerative medicine, PSC has built a network of affiliated physicians and clinics to facilitate the collection and eventual administration of the banked cells. It is a private, likely early-revenue company capitalizing on the growing interest in personalized and regenerative medicine.

Autologous adipose-derived mesenchymal stem cell (MSC) isolation, expansion, and cryopreservation platform for personal banking and future physician-directed administration.

PSC competes with other private stem cell banking services and a vast network of stem cell clinics offering similar point-of-care treatments. Its differentiation is based on claims of FDA-compliant lab processes, cell expansion, and a physician-network model. Long-term competition may come from approved, off-the-shelf allogeneic cell therapies.